Ftse Mib
34.186,18
0,07%
DAX
19.909,14
-0,25%
S&P 500
5.888,72
-0,31%
NASDAQ
19.369,18
-0,60%
Bitcoin
93.972,52
1,41%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lucid Diagnostics Inc (LUCD) Lucid Diagnostics Inc (LUCD) Notizie

Lucid Diagnostics Inc

LUCD
0,8063
0,0062 (0,77%)
Ultimo aggiornamento: 21:05:39
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202414:01PRNUSLucid Diagnostics Granted 180-Day Extension by Nasdaq to..
20/12/202422:15EDGAR2Form 8-K - Current report
19/12/202414:01PRNUSLucid Diagnostics Partners with VITALExam to Enhance..
11/12/202414:01PRNUSProspective Clinical Utility Study of Lucid Diagnostics'..
06/12/202422:10EDGAR2Form D - Notice of Exempt Offering of Securities
03/12/202414:01PRNUSLucid Diagnostics Completes Convertible Debt Refinancing to..
29/11/202422:15EDGAR2Form 8-K - Current report
20/11/202413:56PRNUSLucid Diagnostics Submits Clinical Evidence Package to MolDX..
18/11/202423:27EDGAR2Form 8-K - Current report
18/11/202414:15PRNUSLucid Diagnostics to Present at the Canaccord Genuity..
14/11/202414:01PRNUSPAVmed Provides Business Update and Third Quarter 2024..
13/11/202414:15EDGAR2Form 8-K - Current report
13/11/202414:01PRNUSLucid Diagnostics Provides Business Update and Third Quarter..
12/11/202422:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:00EDGAR2Form 8-K - Current report
07/11/202414:01PRNUSLucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter..
05/11/202414:01PRNUSLucid Diagnostics Expands Direct Contracting Initiative with..
31/10/202413:31PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
30/10/202413:31PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
15/10/202413:51PRNUSLucid Diagnostics Receives Notice of Allowance for Key..
09/10/202414:01PRNUSLucid Diagnostics to Participate in the 2024 Maxim..
08/10/202413:49PRNUSLucid Diagnostics to Join Global Medtech Leaders at The..
01/10/202414:01PRNUSLucid Diagnostics Holds Inaugural #CheckYourFoodTube..
24/9/202414:01PRNUSAmerican Foregut Society's 2024 Annual Meeting to Highlight..
16/9/202422:30PRNUSPAVmed Announces Efforts to Regain Compliance with Nasdaq..
10/9/202413:56PRNUSLucid Diagnostics to Host Symposium on Non-Endoscopic..
03/9/202413:51PRNUSLucid Diagnostics Signs Memorandum of Understanding with..
20/8/202414:16PRNUSLucid Diagnostics Announces Publication of Analytical..
13/8/202414:16PRNUSThe American Foregut Society Formally Requests Medical..
13/8/202414:01PRNUSPAVmed Provides Business Update and Second Quarter 2024..
12/8/202414:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:15EDGAR2Form 8-K - Current report
12/8/202414:07PRNUSLucid Diagnostics Provides Business Update and Second..
08/8/202414:31PRNUSLucid Diagnostics Holds First Major Directly-Contracted..
06/8/202414:15PRNUSLucid Diagnostics Announces Positive Data from ENVET-BE..
05/8/202414:15PRNUSLucid Diagnostics to Participate in Upcoming Investor..
30/7/202414:15PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
29/7/202414:15PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
23/7/202414:01PRNUSLucid Diagnostics Announces Record Quarterly EsoGuard® Test..
19/7/202415:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/7/202422:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/7/202414:31PRNUSLucid Diagnostics Launches New Corporate Website
02/7/202413:55PRNUSLucid Diagnostics Announces Positive Data from its ESOGUARD..
12/6/202414:05PRNUS4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard®..
06/6/202415:48EDGAR2Form DEF 14A - Other definitive proxy statements
06/6/202414:40EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/5/202423:26EDGAR2Form PRE 14A - Other preliminary proxy statements
24/5/202422:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/5/202422:30EDGAR2Form 8-K - Current report
14/5/202412:05EDGAR2Form 8-K - Current report
Apertura: 0,79 Min: 0,78 Max: 0,8219
Chiusura: 0,8001

La tua Cronologia

NASDAQ
LUCD
Lucid Diagnostics
LSE
CYBR
Rizecyber&data
EU
PET4P
Banque Palatine null
AQSE
FIND.GB
WisdomTree Commodity Sec...
AQSE
BEG.GB
Begbies Traynor
BIT
F20407
Vontobel Financial Produ...
BIT
F22741
Vontobel Financial Produ...
BOV
VIVR12F
VIVER
BIT
S29300
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network